Our findings demonstrated that abnormal TIM-1 expression was involved in the progression of human NSCLC, and supported the notion that TIM-1 could serve as an important prognostic risk factor for NSCLC patients. The gene discussed is HAVCR1; the disease is non-small cell lung carcinoma.